IP Library Granted Patent US 7,070,564
Granted Patent B2
US 7,070,564 · App. 10/995,688 · Granted Jul 4, 2006

Devices for physiological fluid sampling and methods of using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,070,564
App. No.
10/995,688
Granted
Jul 4, 2006
Kind
B2
Abstract

Methods and devices are provided for determining a suitable site for sampling physiological fluid. In the subject methods, a potentially suitable physiological sampling site is selected, the fluid flow of the site is characterized and the site is then determined to be suitable based on the whether the site has high or low flow. Suitability may also be determined based on the type of sample obtainable from the site, where the order of the above-described steps may be altered. The subject devices include at least one site flow characterization element for determining the flow characteristics of a potential physiological sampling site and/or at least one sample type characterization element for determining whether the vasculature is arterial, venous or neither, i.e., an interstitial fluid sampling site. The subject methods and devices are particularly suited for use in the detection of physiological sampling sites in the fingers, arms, legs, earlobes, heels, feet, nose and toes. Also provided are kits that include the subject devices for use in practicing the subject methods.

Claims (33)

1. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of

(a) contacting a potentially suitable site with a device configured to determine the type of physiological fluid at said potentially suitable site;

(b) determining the type of physiological fluid at said potentially suitable site; and

(c) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined fluid type.

2. The method according to claim 1 , wherein said step of determining the type of physiological fluid at said potentially suitable site comprises characterizing the hemoglobin of the physiological fluid at said potentially suitable site.

3. The method according to claim 2 , wherein the step of characterizing the hemoglobin comprises determining the hemoglobin concentration of said physiological fluid at said potentially suitable site.

4. The method according to claim 2 , wherein the step of characterizing the hemoglobin comprises determining the concentration of the oxygenated hemoglobin and deoxygenated hemoglobin.

5. The method according to claim 2 , wherein the step of characterizing the hemoglobin comprises determining the ratio of oxygenated hemoglobin to deoxygenated hemoglobin.

6. The method according to claim 1 , further comprising the step of characterizing the flow of physiological fluid at said potentially suitable site.

7. The method according to claim 6 , wherein said step of characterizing the flow comprises determining the temperature at said potentially suitable site.

8. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

(a) contacting a potentially suitable site with a device configured to determine the type of physiological fluid at said potentially suitable site;

(b) determining the type of physiological fluid at said potentially suitable site by characterizing the pulse of said potentially suitable site; and

(c) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined fluid type.

9. The method according to claim 8 , wherein the step of characterizing the pulse of said site comprises characterizing the red blood cells of said physiological fluid at said potentially suitable site.

10. The method according to claim 9 , wherein the step of characterizing red blood cells comprises characterizing red blood cell flux.

11. The method according to claim 8 , further comprising the step of determining the concentration of at least one analyte in said physiological fluid.

12. The method according to claim 11 , wherein said concentration determination comprises transferring a volume of said physiological fluid to an analyte concentration test strip.

13. The method according to claim 11 , wherein said at least one analyte is glucose and said physiological fluid is blood.

14. The method according to claim 11 , wherein an automated meter performs said concentration determination automatically.

15. The method according to claim 8 , wherein said at least one analyte is glucose and said physiological fluid is interstitial fluid.

16. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

(a) contacting a potentially suitable site with a device configured to determine the type of physiological fluid at said potentially suitable site;

(b) determining the type of physiological fluid at said potentially suitable site;

(c) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined fluid type; and

(d) characterizing the flow of said physiological fluid at said potentially suitable site by characterizing the red blood cells of said physiological fluid.

17. A method for determining the suitability of a site for sampling physiological fluid for use in an analyte concentration determination test, said method comprising the steps of:

(a) contacting a potentially suitable site with a device configured to determine the type of physiological fluid at said potentially suitable site;

(b) determining the type of physiological fluid at said potentially suitable site;

(c) determining whether said potentially suitable site is suitable for sampling physiological fluid for use in said analyte concentration determination test, based on said determined fluid type; and

(d) determining the concentration of at least one analyte in said physiological fluid

wherein said at least one analyte is glucose and said physiological fluid is interstitial fluid.

18. The method according to claim 17 , further comprising the step of stimulating the site to enhance the volume of physiological fluid expressed from said site.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
CHANGE OF NAME Recorded Feb 15, 2005
From: NUTOOL, INC.
To: ASM NUTOOL, INC.
Reel/Frame 015723/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2004
From: MATZINGER, DAVID; QURAISHI, KHALID R.
To: LIFESCAN, INC.
Reel/Frame 016031/0554 →